SE424553B - Forfarande for framstellning av nya indazol-derivat - Google Patents
Forfarande for framstellning av nya indazol-derivatInfo
- Publication number
- SE424553B SE424553B SE7613195A SE7613195A SE424553B SE 424553 B SE424553 B SE 424553B SE 7613195 A SE7613195 A SE 7613195A SE 7613195 A SE7613195 A SE 7613195A SE 424553 B SE424553 B SE 424553B
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparing new
- indazol
- derivatives
- indazol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1571675A CH605934A5 (en) | 1975-12-03 | 1975-12-03 | Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs. |
| CH1664575A CH605858A5 (en) | 1975-12-22 | 1975-12-22 | Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs. |
| CH927976 | 1976-07-20 | ||
| CH931276 | 1976-07-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7613195L SE7613195L (sv) | 1977-06-04 |
| SE424553B true SE424553B (sv) | 1982-07-26 |
Family
ID=27429211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7613195A SE424553B (sv) | 1975-12-03 | 1976-11-25 | Forfarande for framstellning av nya indazol-derivat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4086353A (sv) |
| JP (1) | JPS5268177A (sv) |
| AU (1) | AU510820B2 (sv) |
| BE (1) | BE848962A (sv) |
| CA (1) | CA1082714A (sv) |
| DE (1) | DE2653005A1 (sv) |
| DK (1) | DK528976A (sv) |
| ES (1) | ES453861A1 (sv) |
| FI (1) | FI763385A (sv) |
| FR (1) | FR2333504A1 (sv) |
| GB (1) | GB1564327A (sv) |
| IE (1) | IE44316B1 (sv) |
| IL (1) | IL51028A (sv) |
| NL (1) | NL7613317A (sv) |
| NO (1) | NO764039L (sv) |
| NZ (1) | NZ182779A (sv) |
| PH (1) | PH12642A (sv) |
| PT (1) | PT65918B (sv) |
| SE (1) | SE424553B (sv) |
| YU (1) | YU293876A (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436913A (en) * | 1980-09-05 | 1984-03-13 | Siegfried Aktiengesellschaft | 1H- and 2H- indazole derivatives |
| EP1432416B1 (en) * | 2001-09-26 | 2011-01-19 | Pfizer Italia S.r.l. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| SE0402762D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
| SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
| CA2632194C (en) * | 2005-11-15 | 2012-01-03 | Array Biopharma Inc. | N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| CA2633584A1 (en) * | 2005-12-20 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Glucokinase activators |
| KR20090018593A (ko) * | 2007-08-17 | 2009-02-20 | 주식회사 엘지생명과학 | 세포괴사 저해제로서의 인돌 및 인다졸 화합물 |
| WO2009088192A2 (ko) * | 2008-01-04 | 2009-07-16 | Lg Life Sciences Ltd. | 세포, 조직 및 장기 보존 효과를 갖는 인돌 및 인다졸 유도체 |
| KR101404151B1 (ko) * | 2011-11-25 | 2014-06-05 | 가톨릭대학교 산학협력단 | 안과 질환의 예방 및 치료용 약학 조성물 |
| US10221172B2 (en) | 2015-01-13 | 2019-03-05 | Vanderbilt University | Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| WO2016115282A1 (en) | 2015-01-13 | 2016-07-21 | Vanderbilt University | Benzoisoxazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US10526323B2 (en) | 2015-01-30 | 2020-01-07 | Vanderbilt University | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3759903A (en) * | 1971-07-28 | 1973-09-18 | Squibb & Sons Inc | Thiazolinyl and thiazinyl derivatives of indazoles |
-
1976
- 1976-11-22 DE DE19762653005 patent/DE2653005A1/de not_active Withdrawn
- 1976-11-24 DK DK528976A patent/DK528976A/da not_active Application Discontinuation
- 1976-11-24 FI FI763385A patent/FI763385A/fi not_active Application Discontinuation
- 1976-11-25 SE SE7613195A patent/SE424553B/sv unknown
- 1976-11-25 NO NO764039A patent/NO764039L/no unknown
- 1976-11-26 US US05/745,303 patent/US4086353A/en not_active Expired - Lifetime
- 1976-11-30 NL NL7613317A patent/NL7613317A/xx not_active Application Discontinuation
- 1976-11-30 GB GB49834/76A patent/GB1564327A/en not_active Expired
- 1976-12-01 PH PH19181A patent/PH12642A/en unknown
- 1976-12-01 ES ES453861A patent/ES453861A1/es not_active Expired
- 1976-12-01 NZ NZ182779A patent/NZ182779A/xx unknown
- 1976-12-01 JP JP51143543A patent/JPS5268177A/ja active Pending
- 1976-12-01 IE IE2637/76A patent/IE44316B1/en unknown
- 1976-12-01 BE BE172887A patent/BE848962A/xx unknown
- 1976-12-01 IL IL51028A patent/IL51028A/xx unknown
- 1976-12-02 PT PT65918A patent/PT65918B/pt unknown
- 1976-12-02 YU YU02938/76A patent/YU293876A/xx unknown
- 1976-12-02 CA CA267,015A patent/CA1082714A/en not_active Expired
- 1976-12-02 FR FR7636296A patent/FR2333504A1/fr active Granted
- 1976-12-03 AU AU20252/76A patent/AU510820B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IE44316L (en) | 1977-06-03 |
| FR2333504A1 (fr) | 1977-07-01 |
| AU510820B2 (en) | 1980-07-17 |
| JPS5268177A (en) | 1977-06-06 |
| PH12642A (en) | 1979-07-11 |
| US4086353A (en) | 1978-04-25 |
| PT65918B (fr) | 1978-07-05 |
| SE7613195L (sv) | 1977-06-04 |
| GB1564327A (en) | 1980-04-10 |
| BE848962A (fr) | 1977-06-01 |
| IL51028A (en) | 1980-06-30 |
| DK528976A (da) | 1977-06-04 |
| PT65918A (fr) | 1977-01-01 |
| DE2653005A1 (de) | 1977-06-08 |
| IL51028A0 (en) | 1977-02-28 |
| CA1082714A (en) | 1980-07-29 |
| AU2025276A (en) | 1978-06-08 |
| NZ182779A (en) | 1979-08-31 |
| FR2333504B1 (sv) | 1980-08-29 |
| IE44316B1 (en) | 1981-10-21 |
| NL7613317A (nl) | 1977-06-07 |
| NO764039L (sv) | 1977-06-06 |
| FI763385A (sv) | 1977-06-04 |
| ES453861A1 (es) | 1978-03-01 |
| YU293876A (en) | 1982-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7610422L (sv) | Forfarande for framstellning av pyrimidinderivat | |
| SE434394B (sv) | Analogiforfarande for framstellning av kinolonalkansyraderivat | |
| SE434057B (sv) | Forfarande for framstellning av nya rifamycinforeningar | |
| SE440772B (sv) | Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat | |
| SE420201B (sv) | Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat | |
| SE7704545L (sv) | Forfarande for framstellning av nya adeninderivat | |
| SE422065B (sv) | Forfarande for framstellning av nya derivat av tiazolo-(3,4-b)-isokinolin | |
| SE433745B (sv) | Forfarande for framstellning av tetrahydroisokinolinderivat | |
| SE424553B (sv) | Forfarande for framstellning av nya indazol-derivat | |
| SE416479B (sv) | Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller | |
| SE7613768L (sv) | Forfarande for framstellning av penicillinestrar | |
| SE423390B (sv) | Foerfarande foer framstaellning av eburnameninderivat | |
| SE433220B (sv) | Forfarande for framstellning av nya pregnan-derivat | |
| SE423902B (sv) | Forfarande for framstellning av purinderivat | |
| SE431539B (sv) | Analogiforfaranden for framstellning av nya bensylalkoholderivat | |
| SE420493B (sv) | Forfarande for framstellning av nya xantinderivat | |
| SE439159B (sv) | Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat | |
| SE432763B (sv) | Forfarande for framstellning av nya homoftalimider | |
| SE422794B (sv) | Forfarande for framstellning av basiskt substituerade naftalenderivat | |
| SE7612565L (sv) | Forfarande for framstellning av nya rifamycinforeningar | |
| SE435716B (sv) | Forfarande for framstellning av nya penicilliner | |
| SE420093B (sv) | Forfarande for framstellning av 5-fenyl-2-furamidoximer | |
| SE409868B (sv) | Forfarande for framstellning av nya triaminoandrostaner | |
| SE7606815L (sv) | Forfarande for framstellning av nya naftacenderivat | |
| SE7604044L (sv) | Forfarande for framstellning av nya heterocykliska foreningar |